293
Views
56
CrossRef citations to date
0
Altmetric
Clinical Issues

Neurocognitive functioning in HIV-1 infection: effects of cerebrovascular risk factors and age

, , , , , , , & show all
Pages 265-285 | Accepted 09 Nov 2009, Published online: 15 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

April D. Thames, Rodolfo Nunez, George M. Slavich, Michael R. Irwin & Damla Senturk. (2022) Racial differences in health and cognition as a function of HIV among older adults. The Clinical Neuropsychologist 36:2, pages 367-387.
Read now
Monica Rivera Mindt, Caitlin Miranda, Alyssa Arentoft, Desiree Byrd, Jennifer Monzones, Armando Fuentes, Francesca Arias, Miguel Arce Rentería, Ana Rosario & Susan Morgello. (2014) Aging and HIV/AIDS: Neurocognitive Implications for Older HIV-Positive Latina/o Adults. Behavioral Medicine 40:3, pages 116-123.
Read now
Sapna M. Patel, April D. Thames, Natalie Arbid, Stella E. Panos, Steven Castellon & Charles H. Hinkin. (2013) The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals. Journal of Clinical and Experimental Neuropsychology 35:4, pages 421-434.
Read now
Brandon C Dennis, Sidney A Houff, Dong Y Han & Frederick A Schmitt. (2011) Development of neurocognitive disorders in HIV/AIDS. Neurobehavioral HIV Medicine 3, pages 9-18.
Read now
Simon Rackstraw. (2011) HIV-related neurocognitive impairment – A review. Psychology, Health & Medicine 16:5, pages 548-563.
Read now

Articles from other publishers (51)

Roger C McIntosh, Uraina S Clark, Mariana Cherner, Lucette A Cysique, Robert K Heaton, Jules Levin, Robert H Remien, April Thames, David J Moore & Leah H Rubin. (2023) The Evolution of Assessing Central Nervous System Complications in Human Immunodeficiency Virus: Where Do We Go From Here?. The Journal of Infectious Diseases 227:Supplement_1, pages S30-S37.
Crossref
Charlotte Bernard, Hélène Font, Zélica Diallo, Richard Ahonon, Judicaël Malick Tine, Franklin N'Guessan Abouo, Aristophane Tanon, Eugène Messou, Moussa Seydi, François Dabis, Jean‐François Dartigues & Nathalie de Rekeneire. (2022) Factors associated with verbal fluency in older adults living with HIV in West Africa: A longitudinal study . Tropical Medicine & International Health 28:1, pages 35-42.
Crossref
Rowan Saloner, Ni Sun-Suslow, Erin E. Morgan, Judith Lobo, Mariana Cherner, Ronald J. Ellis, Robert K. Heaton, Igor Grant, Scott L. Letendre & Jennifer E. Iudicello. (2022) Plasma biomarkers of vascular dysfunction uniquely relate to a vascular-risk profile of neurocognitive deficits in virally-suppressed adults with HIV. Brain, Behavior, & Immunity - Health 26, pages 100560.
Crossref
Isabella Zanella, Eliana Zacchi, Chiara Fornari, Benedetta Fumarola, Melania Degli Antoni, Daniela Zizioli & Eugenia Quiros-Roldan. (2022) An exploratory pilot study on the involvement of APOE, HFE, C9ORF72 variants and comorbidities in neurocognitive and physical performance in a group of HIV-infected people. Metabolic Brain Disease 37:5, pages 1569-1583.
Crossref
Daniel Ojeda-Juárez & Marcus Kaul. (2021) Transcriptomic and Genetic Profiling of HIV-Associated Neurocognitive Disorders. Frontiers in Molecular Biosciences 8.
Crossref
Vanessa A. Guzman, Heining Cham, Jose Gutierrez, Desiree Byrd, Emily P. Morris, Kayla Tureson, Susan Morgello & Monica R. Mindt. (2021) The Longitudinal Effects of Blood Pressure and Hypertension on Neurocognitive Performance in People Living With HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes 88:2, pages 197-205.
Crossref
Sarah A. Cooley, Jaimie Navid, Julie K. Wisch, Anna Boerwinkle, John Doyle, Robert H. Paul & Beau M. Ances. (2021) Relationships Between Viral Load, Neuroimaging, and NP in Persons Living With HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes 87:3, pages 985-992.
Crossref
Elissa C. McIntosh, Kayla Tureson, Lindsay J. Rotblatt, Elyse J. Singer & April D. Thames. (2020) HIV, Vascular Risk Factors, and Cognition in the Combination Antiretroviral Therapy Era: A Systematic Review and Meta-Analysis. Journal of the International Neuropsychological Society 27:4, pages 365-381.
Crossref
Htein Linn Aung, Maral Aghvinian, Hetta Gouse, Reuben N. Robbins, Bruce J. Brew, Limin Mao & Lucette A. Cysique. (2020) Is There Any Evidence of Premature, Accentuated and Accelerated Aging Effects on Neurocognition in People Living with HIV? A Systematic Review. AIDS and Behavior 25:3, pages 917-960.
Crossref
Terrence Chan, Monica Marta, Camilla Hawkins & Simon Rackstraw. (2020) Cognitive and Neurologic Rehabilitation Strategies for Central Nervous System HIV Infection. Current HIV/AIDS Reports 17:5, pages 514-521.
Crossref
Pamela E. May, Abigail J. Heithoff, Christopher S. Wichman, Vaishali S. Phatak, David J. Moore, Robert K. Heaton & Howard S. Fox. (2020) Assessing Cognitive Functioning in People Living With HIV (PLWH): Factor Analytic Results From CHARTER and NNTC Cohorts. JAIDS Journal of Acquired Immune Deficiency Syndromes 83:3, pages 251-259.
Crossref
Adria Quigley, Marie-Josée Brouillette, Jacqueline Gahagan, Kelly Kathleen O’Brien & Marilyn MacKay-Lyons. (2020) Feasibility and Impact of a Yoga Intervention on Cognition, Physical Function, Physical Activity, and Affective Outcomes among People Living with HIV: A Randomized Controlled Pilot Trial. Journal of the International Association of Providers of AIDS Care (JIAPAC) 19, pages 232595822093569.
Crossref
Shih-Ping Lin, Andrea Calcagno, Scott L. Letendre & Qing Ma. 2021. Neurocognitive Complications of HIV-Infection. Neurocognitive Complications of HIV-Infection 517 545 .
Antoine Moulignier & Dominique Costagliola. 2021. Neurocognitive Complications of HIV-Infection. Neurocognitive Complications of HIV-Infection 367 399 .
Monica G. Rivera Mindt, Desiree A. Byrd, Emily P. Morris, Kayla Tureson, Vanessa Guzman, Angela C. Summers, Cara Crook, Micah J. Savin & Maral Aghvinian. 2021. Neurocognitive Complications of HIV-Infection. Neurocognitive Complications of HIV-Infection 193 223 .
Julian Falutz, Susan Kirkland & Giovanni Guaraldi. 2021. Neurocognitive Complications of HIV-Infection. Neurocognitive Complications of HIV-Infection 301 327 .
E. Merlini, F. Iannuzzi, A. Calcagno, F. Bai, M. Trunfio, A. d’Arminio Monforte, S. Bonora & Giulia Marchetti. (2018) Peripheral and cerebrospinal fluid immune activation and inflammation in chronically HIV-infected patients before and after virally suppressive combination antiretroviral therapy (cART). Journal of NeuroVirology 24:6, pages 679-694.
Crossref
Isaac H. Solomon, Umberto De Girolami, Sukrutha Chettimada, Vikas Misra, Elyse J. Singer & Dana Gabuzda. (2017) Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era. BMC Infectious Diseases 17:1.
Crossref
Hamza Coban, Kevin Robertson, Marlene Smurzynski, Supriya Krishnan, Kunling Wu, Ronald J. Bosch, Ann C. Collier & Ronald J. Ellis. (2017) Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen. AIDS 31:11, pages 1565-1571.
Crossref
Christa Watson, Edgar Busovaca, Jessica M. Foley, I. Elaine Allen, Christopher G. Schwarz, Neda Jahanshad, Talia M. Nir, Pardis Esmaeili-Firidouni, Benedetta Milanini, Howard Rosen, Owen T. Carmichael, Paul M. Thompson & Victor G. Valcour. (2017) White matter hyperintensities correlate to cognition and fiber tract integrity in older adults with HIV. Journal of NeuroVirology 23:3, pages 422-429.
Crossref
Kathryn N. Devlin & Tania Giovannetti. (2017) Heterogeneity of Neuropsychological Impairment in HIV Infection: Contributions from Mild Cognitive Impairment. Neuropsychology Review 27:2, pages 101-123.
Crossref
Jessica L. Montoya, Jennifer Iudicello, Hannah A. Oppenheim, Pariya L. Fazeli, Michael Potter, Qing Ma, Paul J. Mills, Ronald J. Ellis, Igor Grant, Scott L. Letendre & David J. Moore. (2017) Coagulation imbalance and neurocognitive functioning in older HIV-positive adults on suppressive antiretroviral therapy. AIDS 31:6, pages 787-795.
Crossref
Nancy E. Mayo, Marie-Josée Brouillette & Lesley K. Fellows. (2016) Understanding and optimizing brain health in HIV now: protocol for a longitudinal cohort study with multiple randomized controlled trials. BMC Neurology 16:1.
Crossref
Ronald Ellis & Scott L. Letendre. (2016) Update and New Directions in Therapeutics for Neurological Complications of HIV Infections. Neurotherapeutics 13:3, pages 471-476.
Crossref
Kalavathi Dasuri, Jennifer K. Pepping, Sun-OK Fernandez-Kim, Sunita Gupta, Jeffrey N. Keller, Philipp E. Scherer & Annadora J. Bruce-Keller. (2016) Elevated adiponectin prevents HIV protease inhibitor toxicity and preserves cerebrovascular homeostasis in mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1862:6, pages 1228-1235.
Crossref
Deanna Saylor & Ned Sacktor. (2016) Cognitive Impairment Among Older Individuals with HIV Infection. Current Geriatrics Reports 5:2, pages 63-70.
Crossref
C.L. Nemeth, M. Bekhbat & G.N. Neigh. (2015) Neural effects of inflammation, cardiovascular disease, and HIV: Parallel, perpendicular, or progressive?. Neuroscience 302, pages 165-173.
Crossref
Gary B. Fogel, Susanna L. Lamers, Andrew J. Levine, Miguel Valdes-Sueiras, Michael S. McGrath, Paul Shapshak & Elyse J. Singer. (2014) Factors related to HIV-associated neurocognitive impairment differ with age. Journal of NeuroVirology 21:1, pages 56-65.
Crossref
Ellen M. Tedaldi, Nancy L. Minniti & Tracy Fischer. (2015) HIV-Associated Neurocognitive Disorders: The Relationship of HIV Infection with Physical and Social Comorbidities. BioMed Research International 2015, pages 1-13.
Crossref
C.-H. Tseng, W.-S. Huang, C.-H. Muo & C.-H. Kao. (2014) Increased risk of dementia among chronic osteomyelitis patients. European Journal of Clinical Microbiology & Infectious Diseases 34:1, pages 153-159.
Crossref
Bertrand Lebouché, Mohammad-Ali Jenabian, Joel Singer, Gina M Graziani, Kim Engler, Benoit Trottier, Réjean Thomas, Marie-Josée Brouillette & Jean-Pierre Routy. (2014) The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy – CTN PT006: study protocol for a randomized controlled trial. Trials 15:1.
Crossref
Susan MorgelloJacinta MurraySarah Van Der ElstDesiree Byrd. (2014) HCV, but not HIV, is a risk factor for cerebral small vessel disease. Neurology Neuroimmunology & Neuroinflammation 1:3.
Crossref
Robert C. Kalayjian, Kunling Wu, Scott Evans, David B. Clifford, Muraldihar Pallaki, Judith S. Currier & Marlene Smryzynski. (2014) Proteinuria is Associated With Neurocognitive Impairment in Antiretroviral Therapy Treated HIV-Infected Individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes 67:1, pages 30-35.
Crossref
Lewis J. HaddowCristina DudauHoskote ChandrashekarJonathan D. CartledgeHarpreet HyareRobert F. MillerH. Rolf Jäger. (2014) Cross-Sectional Study of Unexplained White Matter Lesions in HIV Positive Individuals Undergoing Brain Magnetic Resonance Imaging. AIDS Patient Care and STDs 28:7, pages 341-349.
Crossref
Jennifer K. Pepping, Laszlo OtvosJr.Jr., Eva Surmacz, Sunita Gupta, Jeffrey N. Keller & Annadora J. Bruce-Keller. (2014) Designer Adiponectin Receptor Agonist Stabilizes Metabolic Function and Prevents Brain Injury Caused by HIV Protease Inhibitors. Journal of Neuroimmune Pharmacology 9:3, pages 388-398.
Crossref
José A. Muñoz-Moreno, Maria J. Fuster-Ruiz de Apodaca, Carmina R. Fumaz, Maria J. Ferrer, Fernando Molero, Àngels Jaen, Bonaventura Clotet & David Dalmau. (2014) Quejas cognitivas en personas con infección por el virus de la inmunodeficiencia humana en España: prevalencia y variables relacionadas. Medicina Clínica 142:10, pages 438-444.
Crossref
Jennifer E. Iudicello, Erin E. Morgan, Assawin Gongvatana, Scott L. Letendre, Igor Grant & Steven Paul Woods. (2014) Detrimental impact of remote methamphetamine dependence on neurocognitive and everyday functioning in older but not younger HIV+ adults: evidence for a legacy effect?. Journal of NeuroVirology 20:1, pages 85-98.
Crossref
Anton Pozniak, Simon Rackstraw, Jane Deayton, Tristan Barber, Steve Taylor, Hadi Manji, Diane Melvin, Michelle Croston, Sam Nightingale, Ranubabu Kulasegaram, Mervi Pitkanen & Alan Winston. (2014) Hiv-Associated Neurocognitive Disease: Case Studies and Suggestions for Diagnosis and Management in Different Patient Subgroups. Antiviral Therapy 19:1, pages 1-13.
Crossref
David E. Vance, Graham J. McDougall, Natalie Wilson, Marcus Otavio Debiasi & Shameka L. Cody. (2014) Cognitive Consequences of Aging With HIV. Topics in Geriatric Rehabilitation 30:1, pages 35-45.
Crossref
Catherine A. Dufour, Maria J. Marquine, Pariya L. Fazeli, Brook L. Henry, Ronald J. Ellis, Igor Grant & David J. Moore. (2013) Physical exercise is associated with less neurocognitive impairment among HIV-infected adults. Journal of NeuroVirology 19:5, pages 410-417.
Crossref
Linda Nabha, Lan Duong & Joseph Timpone. (2013) HIV-Associated Neurocognitive Disorders: Perspective on Management Strategies. Drugs 73:9, pages 893-905.
Crossref
A. Antinori, G. Arendt, I. Grant, S. Letendre, Chair, J. A. Munoz-Moreno, C. Eggers, B. Brew, M.-J. Brouillette, F. Bernal-Cano, A. Carvalhal, P. P. Christo, P. Cinque, L. Cysique, R. Ellis, I. Everall, J. Gasnault, I. Husstedt, V. Korten, L. Machala, M. Obermann, S. Ouakinin, D. Podzamczer, P. Portegies, S. Rackstraw, S. Rourke, L. Sherr, A. Streinu-Cercel, A. Winston, V. Wojna, Y. Yazdanpannah, G. Arbess, J.-G. Baril, J. Begovac, C. Bergin, P. Bonfanti, S. Bonora, K. Brinkman, A. Canestri, G. Cholewinska-Szymanska, M. Chowers, J. Cooney, M. Corti, C. Doherty, D. Elbirt, S. Esser, E. Florence, G. Force, J. Gill, J.-C. Goffard, T. Harrer, P. Li, L. V. de Kerckhove, G. Knecht, S. Matsushita, R. Matulionyte, S. McConkey, A. Mouglignier, S. Oka, A. Penalva, K. Riesenberg, H. Sambatakou, V. Tozzi, M. Vassallo, P. Wetterberg & A. W. Drapato. (2012) Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program. Clinical Infectious Diseases 56:7, pages 1004-1017.
Crossref
M Fabbiani, N Ciccarelli, M Tana, S Farina, E Baldonero, V Di Cristo, M Colafigli, E Tamburrini, R Cauda, MC Silveri, P Grima & S Di Giambenedetto. (2012) Cardiovascular risk factors and carotid intima‐media thickness are associated with lower cognitive performance in HIV ‐infected patients . HIV Medicine 14:3, pages 136-144.
Crossref
JA McCombe, P Vivithanaporn, MJ Gill & C Power. (2013) Predictors of symptomatic HIV-associated neurocognitive disorders in universal health care. HIV Medicine 14:2, pages 99-107.
Crossref
Pierfrancesco Grima, Massimiliano Fabbiani, Nicoletta Ciccarelli, Mariangela Tana, Salvatore Farina, Manuela Colafigli, Annalisa Mondi, Roberto Cauda & Simona Di Giambenedetto. (2012) Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients. Journal of Infection 65:5, pages 439-446.
Crossref
Belinda Cruse, Lucette A. Cysique, Romesh Markus & Bruce J. Brew. (2012) Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy. Journal of NeuroVirology 18:4, pages 264-276.
Crossref
Sunita Gupta, Alecia G. Knight, Boriss Y. Losso, Donald K. Ingram, Jeffrey N. Keller & Annadora J. Bruce-Keller. (2012) Brain injury caused by HIV protease inhibitors: Role of lipodystrophy and insulin resistance. Antiviral Research 95:1, pages 19-29.
Crossref
J. Cobb Scott, Steven Paul Woods, Catherine L. Carey, Erica Weber, Mark W. Bondi & Igor Grant. (2010) Neurocognitive Consequences of HIV Infection in Older Adults: An Evaluation of the “Cortical” Hypothesis. AIDS and Behavior 15:6, pages 1187-1196.
Crossref
. (2011) Current World Literature. Current Opinion in Neurology 24:3, pages 300-307.
Crossref
Judith Schouten, Paola Cinque, Magnus Gisslen, Peter Reiss & Peter Portegies. (2011) HIV-1 infection and cognitive impairment in the cART era: a review. AIDS 25:5, pages 561-575.
Crossref
Lauren Malaspina, Steven Paul Woods, David J. Moore, Colin Depp, Scott L. Letendre, Dilip Jeste & Igor Grant. (2010) Successful cognitive aging in persons living with HIV infection. Journal of NeuroVirology 17:1, pages 110-119.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.